Article
The natural HLA-Peptidome of Sezary Syndrome: uncovering antigens for T cell-based immunotherapy
2024-12-25
Abstract excerpt
Sezary syndrome (SS) is a rare and aggressive form of cutaneous T-cell lymphoma, that has a poor prognosis, with a median overall survival time of less than 3 years. Despite advances in its treatment, SS is a challenge to manage, often characterized by high rates of relapse and limited response to therapy in many patients. The main challenge for treatment, including vaccine development is its heterogeneity. In its...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 82903226-3239-5032-a41b-a299814b0cf5
- DOI
- 10.1101/2024.12.25.630030
